ArticleJournal of hepatocellular carcinoma2025

ALBI Grade Enables Risk Stratification for Bleeding Events and Refines Prognostic Prediction in Advanced HCC Following Atezolizumab and Bevacizumab.

Bernardo Stefanini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.